With the aid of anew fracture risk model, the great treatment gap for osteoporosis should be closed. All patients older than 70years should undergo a diagnostic procedure for osteoporosis. An additional risk threshold (≥ 10% per 3years for femoral and vertebral fractures) should enable patients with ahigh risk of fracture to be treated with osteoanabolic agents. The use of osteoanabolic agents makes it necessary to administer antiresorptive drugs afterwards. Due to the low event rate of osteonecrosis of the jaw, the initiation of aspecific osteoporosis treatment should not be delayed by prophylactic dental treatment. The adherence to the drug treatment should be improved by an individualized approach on the basis of acooperation between patients, caregivers, and physicians. Aregular assessment of falls, including the timed up and go test should be carried out in patients older than 70years.